Actively Recruiting
Ayahuasca, Esketamine and PTSD
Led by University of Sao Paulo · Updated on 2026-01-05
10
Participants Needed
1
Research Sites
27 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Double-blind, randomized trial comparing a single dose of oral ayahuasca or esketamine in patients with posttraumatic stress disorder.
CONDITIONS
Official Title
Ayahuasca, Esketamine and PTSD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of posttraumatic stress disorder
You will not qualify if you...
- Presence of other psychiatric or medical conditions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital das Clínicas da FMRP-USP
Ribeirão Preto, São Paulo, Brazil, 14049900
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here